Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)

NCT00238875 is registered in ClinicalTrials.gov with Haruhiko Fukuda as lead sponsor.

NCT NCT00238875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00238875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)
Lead sponsor
Haruhiko Fukuda
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2004
Completion date
November 30, 2011
Enrollment
167 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

t1n0m0 non-small cell lung cancer